Phenotype | Intended designation |
---|---|
1. CD45loCD34+ | ISHAGE protocol |
2. Lin-CD45loCD34+ | Hematopoietic progenitors |
3. Lin-CD45loCD34+CD133+CD117+ | Hematopoietic stem cells* |
4. Lin-CD45-CD133+CD31+CD144+KDR+ | Endothelial precursor* |
5. Lin-CD45-CD133-CD31+CD144+KDR+ | Endothelial cell* |
6. CD45+CD10+CD33+HLA-DR-CD45RA- | Myeloid precursor* |
7. CD45+CD10+CD33-HLA-DR+CD45RA+ | Lymphoid precursor* |
8. CD45-CD133+CD146+CD144+CD166+ | Mesenchymal progenitor* |
9. CD45-CD133-CD146+CD73+CD166+ | Mesenchymal cell* |
10. CD45+CD10+CD34+CD19-CD38-TdT+IgM- | pre-pro-B intermediary |
10.1. CD45+CD10+CD34+CD19+CD38-TdT+IgM- | pro-B/pre-B I intermediary |
10.2. CD45+CD10+CD34-CD19+CD38-TdT-IgM- | Pre-B II intermediary |
10.3. CD45+CD10-CD34-CD19+CD38+TdT-IgM+CD24hi | Immature B LΦ |
10.4. CD45+CD10-CD34-CD19+CD38+TdT-IgM+ | Naïve B LΦ |
10.5. CD45+CD10-CD34-CD19+CD38+TdT-IgM+CD24loCD69+ | Mature B LΦ |
11. CD45+CD34+CD38-CD1a-CD3-CD4-CD8- | LΦ-T DN1 |
11.1. CD45+CD34+CD38+CD1a-CD3-CD4-CD8- | LΦ-T DN2 |
11.2. CD45+CD34+CD38+CD1a+CD3-CD4-CD8- | LΦ-T DN3 |
11.3. CD45+CD34+CD38+CD1a+CD3loCD4+CD8- | LΦ-T DN4-ISP |
11.4. CD45+CD34+CD38+CD3-CD4+CD8+ | LΦ-T DP |
11.5. CD45+CD34+CD38+CD3+CD4+CD8+ | LΦ-T DP-CD3 |
12. CD45+CD34+CD3+CD4+CD8- | LΦ-T CD4 |
13. CD45+CD34+CD3+CD4-CD8+ | LΦ-T CD8 |
14. CD45+CD122+CD56+CD3- | NK cells |
15. CD45+CD66acde+ | Neutrophils/Basophils |
16. CD45+CD41a+ | Megakaryocytes |
17. CD45+CD66acde-CD41a-CD14+CD16+ | Monocytes/Macrophages |